Korea Joongang Daily on MSN8h
Samsung Biologics, LigaChem Biosciences expand cancer treatment collaborationSamsung Biologics and Ligachem Biosciences will expand their collaboration on projects to develop antibody-drug conjucates ...
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback